About Sensorion

Company Description

Sensorion’s mission is to offer innovative therapeutic solutions providing long-term improvements to people living with, or at risk of, inner ear disorders. Sensorion’s portfolio of solutions to unmet medical and social needs in inner ear disorders rests on three pillars – Restore, Treat, Prevent.

Restore
We aim to restore hearing by treating genetic diseases previously regarded as untreatable.

Treat
We aim to treat hearing disorders through innovative small molecule therapeutic solutions.

Prevent
We aim to prevent non-genetic hearing loss (e.g drug or surgery-related) through targeted therapeutic programs.

Year founded

2009

Served area

Worldwide

Headcount

34

Headquarters

375 Rue du Professeur Joseph Blayac, 34080 Montpellier – France

Shareholder information

Shares outstanding

79,937,938

IPO

April 21, 2015

Stock exchange(s)

Euronext Paris

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.